Fabomotizole

DB13623InvestigationalSmall molecule

Fabomotizole: Overview.

Mechanism: Pharmacologically active on Sigma non-opioid intracellular receptor 1, Ribosyldihydronicotinamide dehydrogenase [quinone], and Melatonin receptor type 1A
Curator reviewed
Formula / weight: C₁₅H₂₁N₃O₂S · 307.41 g/mol (avg)
Code names: CM-346

Resolves to

Compound

UNII0F8K1X115CCAS173352-21-1ChEMBLCHEMBL3707307ChEBI135309

Clinical / RWD

ATCN05BX04

Structure

InChIKeyWWNUCVSRRUDYPP-UHFFFAOYSA-NSMILESCCOC1=CC=C2NC(SCCN3CCOCC3)=NC2=C1

Targets

Q99720SIGMAR1P16083NQO2P48039MTNR1AP21397MAOAQ5BJF2TMEM97

What you can answer from here — as of July 07, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

666Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 5 drug categories

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fabomotizole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In